aTYR PHARMA INC (ATYR) — Insider Trading

Key Insights

• The reporting person, Nancy Denyes, acquired 31,555 shares of aTYR PHARMA INC (ATYR) common stock through the company's 2015 Employee Purchase Plan in multiple transactions.
• Denyes was granted a stock option to purchase 412,500 shares of ATYR common stock at an exercise price of $0.7127 per share, which will vest in 36 equal monthly installments starting February 9, 2026.
• The stock option is subject to accelerated vesting upon termination without cause upon a change of control of the issuer, providing an incentive for Denyes to remain with the company during a potential acquisition.